Pembrolizumab in advanced melanoma: Added benefit for certain patients

Certain adults with pretreatment have fewer side effects under pembrolizumab. Treatment-naive patients without tumor mutation survive longer and have better social participation, report reviewers.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1jgkaDd